We report the findings of a randomised controlled triple-blind pilot study of intraoperative ketamine infusion combined with spinal anaesthesia on the prevalence of persisting post surgical pain following total knee arthroplasty surgery. Twelve patients were randomised to receive either ketamine or placebo in association with spinal anaesthesia for total knee arthroplasty. All patients also received general anaesthesia. More patients were pain-free at six months in the ketamine group (three of five) compared to the control group (two of seven). Perioperative data collected during the study suggested that the addition of intraoperative ketamine might also improve the quality of recovery. Although no statistical analysis was undertaken due to the small numbers, these preliminary findings suggest that the use of intraoperative systemic ketamine in association with spinal anaesthesia for the reduction of persisting post surgical pain deserves further study.
De Kock et al 1 and Lavand'homme et al 2 found that intraoperative systemic ketamine infusion, when used in association with epidural blockade, reduced the incidence of residual pain six months following abdomino-perineal resection. Lavand'homme et al 2 demonstrated that this reduction was independent of the postoperative analgesic regimen employed. Follow-up studies investigating the effect of intraoperative ketamine on persisting post surgical pain (PPSP) have been disappointing, but so far they have not included simultaneous intraoperative neuraxial blockade 3, 4 .
Approximately one million total knee arthroplasty (TKA) procedures are performed annually worldwide. Knee pain unresponsive to conservative therapies is the primary indication for TKA surgery in 84% of patients 5 . Longitudinal studies of individual pain outcome following TKA have not been published, although many authors [5] [6] [7] [8] report high incidences of PPSP following TKA. To date, no intervention has demonstrated efficacy in reducing the incidence of PPSP following major orthopaedic surgery 9 .
METHODS
The study was conducted at a major regional public hospital following the approval of our institution's Ethics Committee. Informed consent was obtained from all participants.
The planned study was a controlled, randomised, triple-blind clinical trial to assess the combination of spinal anaesthesia and intraoperative ketamine infusion on the prevalence of PPSP at six months following TKA. Recruitment difficulties led to an abandonment of our intended enrolment in the early stages. The study continued as a pilot investigation over a reduced time scale.
Patients were eligible if they were booked for an elective unilateral, two or three compartment TKA with an American Society of Anesthesiologists Physical Status Classification of I to III. Patients were informed of the study by an information sheet at the time of booking and consent was obtained approximately one week in advance of surgery.
Patients were excluded if body mass index exceeded 50, daily opiate use exceeded a systemic morphine equivalent of 10 mg or if a history of psychosis was elicited.
Patients were to be withdrawn following randomisation if the anaesthetist believed it to be medically inadvisable to proceed with trial protocol because of physiological vulnerability, the anaesthetist failed to complete the operative
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Anaesthesia and Intensive Care, Vol. 37, No. 2, March 2009 protocol in its entirety, poor pain control during the first 48 hours postoperatively required an alternative analgesic regimen or if a second operation was performed on the ipsilateral knee in the six-month follow-up period.
Our measure of PPSP, in the months following surgery, was the pain sub-scale component (WPS) of the Womac™ (Western Ontario and MacMaster university Osteoarthritis) Index 10 . Following consent, demographic data were collected and the WPS score collated. Patients were randomised to "Syringe A" or "Syringe B" with both prepared offsite (Baxter™) to achieve triple blinding. The sealed syringe code was stored in our pharmacy department.
In the operating room an intrathecal injection of 15 mg plain bupivacaine + 100 µg morphine 11 was administered. Following the onset of leg weakness, general anaesthesia was induced within the following parameters; airway management as appropriate to patient requirements and end-tidal volatile ≥0.5 MAC or propofol infusion with appropriate anaesthetic depth monitoring. Strict limits were placed on intraoperative opiates and no pre-or intraoperative benzodiazepines were to be administered.
Through a dedicated line, a programmed syringe delivered ketamine 0.5 mg/kg bolus followed by 4 µg/kg/min infusion, or equivalent volumes of the control (saline) solution. The infusion commenced before surgical incision and continued until the surgical wound was bandaged or the syringe was empty.
Each patient was assessed on arrival in the recovery room for any psychomimetic effects and if present, 1 mg of midazolam was administered intravenously.
All patients received oral paracetamol (1.5 g) as soon as they were able to swallow safely and the following analgesic regimen was then employed: 750 mg paracetamol every four hours strictly;
commenced in the recovery room -morphine 2 mg boluses with a 10 minute lockout; Nurse-initiated morphine rescue 2.5 mg • intravenously 10 minutely as required in event of severe pain (pain score >8/10 on movement); and Ibuprofen 800 mg orally as 'rescue' (× 1) if a • delay in PCA dose adjustment by our acute pain team was anticipated. If pain remained greater than 8/10 (after PCA adjustment), the patient was withdrawn from the trial and additional analgesia methods were instituted. PCA was adjusted up or down as required for patient needs. Following hospital discharge, the WPS at four, 12 and 26 weeks post TKA were collected, using a standardised telephone interview. Surgical review was facilitated if there was no improvement in WPS relative to the preoperative score at the 12 or 26 week interview. The purpose of this review was to exclude the presence of mechanical failure or infection as a cause of severe pain.
Primary outcome measures
Incidence of pain at six months equal to or worse 1.
than that preoperatively using WPS; Incidence of zero pain in operated knee at six 2. months using WPS; Presence of pain not meeting the above criteria, 3.
arbitrarily labelled mild/moderate.
Statistical analysis
Due to the small number of patients, no inferential statistical analysis was undertaken and the results are presented in a descriptive manner only. 
RESuLTS
Sixteen patients were randomised to participating physicians; four failed to complete the protocol, three had intraoperative protocol breaches and one patient had uncontrolled postoperative pain.
The results for the 12 patients who completed the study are presented below. Of note was a high prevalence of zero pain at six months, by WPS, in the patients who received ketamine. Figures 1 and 2 demonstrate the course of the WPS scores for each patient during the first six months postoperatively. A suggestion of an accelerated improvement in WPS scores at four weeks in the ketamine patients is evident in Figure 2 , compared to the more gradual improvement over time in the control group. The average improvement from preoperative WPS scores at four weeks was 5.2 in the ketamine group compared with 1.4 in the control arm. There was only one episode of an adverse psychomimetic effect, which was mild. This occurred following a rapid TKA procedure in which the patient arrived in the post-anaesthetic room within 90 minutes of the onset of spinal anaesthesia.
DISCuSSION
The observation of interest in this series of patients was the number of patients in the ketamine arm with zero WPS at 26 weeks. Although the numbers were very small, the finding that 60% of patients in our ketamine arm (three out of five) were pain-free at six months was surprising, especially when compared to the low percentage in the control group (<30%). This improved pain outcome in the ketamine arm was generally evident by four weeks. Although statistical analysis was not undertaken, the findings are nevertheless very encouraging and indicate that this technique warrants further investigation.
An increase in pain-free outcome in the ketamine arm was demonstrated by the De Kock et al 1 and Lavand'homme et al 2 studies whose primary outcome was a reduction in prevalence of PPSP. We cannot exclude differences in patient characteristics in the ketamine group (weight, body mass index, age or duration of surgery) contributing to the higher pain free outcome or an arbitrary effect of small numbers.
The prevalence of no PPSP following TKA, using a validated knee scoring system with data collected prospectively, has not been published. However, unpublished anecdotal reports suggest that prevalence of no PPSP is low. For example, a postal survey of 8331 TKA patients who underwent surgery in England in 2003 found that that only 20% were pain free using the Oxford Knee Score at 12 months (P. Baker, personal communication). Similarly, another anecdotal report indicated that the prevalence of pain free outcome at six months was 16.5% (49 of 296 patients) (H. Razmjou, personal communication).
Ketamine has several actions that have created interest in its use as a pre-emptive anti-hyperalgesic agent for the prevention of PPSP. The most well known action is reversible NMDA receptor antagonism thought to be responsible for suppression of secondary hyperalgesia and central sensitisation.
Ketamine is known to reduce pro-inflammatory cytokine release 12 potentially reducing primary hyperalgesia. It has also demonstrated weak local anaesthetic activity which may alter the response of neuronal sodium channels to nerve injury 13 . Ketamine also attenuates opiate induced hyperalgesia 14 .
Any of these individual mechanisms may be contributing to PPSP following apparently successful surgery. Primary hyperalgesia around the knee joint has been documented preoperatively 15 in TKA patients and its presence was associated with increased perioperative morphine consumption, but the influence on PPSP has not been studied. Harden et al 16 found two of 77 of patients exhibited hyperalgesia and allodynia six months following TKA surgery with other features consistent with complex regional pain syndrome.
Current evidence would suggest the most common mechanism for a severe pain outcome is subtle mechanical alignment problems 17 . Intraoperative therapies are unlikely to influence pain of ongoing mechanical origin, however hyperalgesia may contribute to lesser degrees of PPSP following TKA and may be amenable to a 'pre-emptive' effect of ketamine combined with spinal anaesthesia. Early improvement in pain outcome amongst the ketamine group would support the anti-hyperalgesic hypothesis behind this anaesthetic regimen and has the potential to facilitate earlier detection of postoperative mechanical problems by enhancing pain improvement in patients with a mechanically sound result. A low incidence of side-effects from the administration of ketamine was found. This is consistent with findings of other authors 18 .
The Womac Pain Scale was chosen in preference to a numerical rating scale, as the Womac™ index is a well validated measure of outcome following therapeutic interventions for knee arthritis 19 . The functional measures of this index were not recorded. The WPS is a Likert 5-point scale during five activities. The range for each activity is 0 to 4 giving the most intense pain a score of 20.
An incidental finding also requiring confirmation is a potential improvement in quality of recovery as illustrated by the lower morphine consumption in the ketamine group on the second postoperative day, combined with a reduction in the overall number of PONV events in the first 48 hours (1.6 episodes per patient in the control group vs. 0.75 episodes per patient in the ketamine group).
The apparent reduction in morphine consumption would be consistent with a basic science investigation of Van Elstraete et al 14 , who were able demonstrate a prolonged inhibition of hyperalgesia in mice that received intrathecal morphine combined with systemic ketamine. It was not possible to determine whether the effect on postoperative nausea and vomiting was due to this reduced morphine consumption during the second 24 hours, or an intrinsic property of the prior ketamine infusion.
The ideal anaesthetic and analgesic technique for TKA surgery has not been established. Femoral, sciatic or epidural blockade do not appear to influence long-term residual pain or functional outcome following TKA [20] [21] [22] . Single-shot femoral nerve blockade has gained popularity with multiple studies demonstrating a large morphine sparing effect during the first postoperative day following TKA surgery. At the time of trial conception, the effect of nerve blockade on PPSP was unclear and was not considered for our protocol. The influence of spinal anaesthesia on long-term outcome following TKA has not been reported.
Should subsequent research confirm the effectiveness and safety of intraoperative systemic ketamine in association with spinal blockade in preventing PPSP, the simplicity of the technique may have utility for other lower limb procedures in both first world and developing nations.
In conclusion, some degree of PPSP appears to be common following TKA. The findings of this pilot study indicate that intraoperative ketamine, when used in association with spinal and general anaesthesia, may reduce the prevalence of PPSP following TKA and may also improve the quality of recovery. This technique would appear worthy of closer scrutiny in the absence of other interventions demonstrating such potential.
